Related references
Note: Only part of the references are listed.Rational antibody-based HIV-1 vaccine design: current approaches and future directions
Laura M. Walker et al.
CURRENT OPINION IN IMMUNOLOGY (2010)
Elicitation of structure-specific antibodies by epitope scaffolds
Gilad Ofek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Computational Design of Epitope-Scaffolds Allows Induction of Antibodies Specific for a Poorly Immunogenic HIV Vaccine Epitope
Bruno E. Correia et al.
STRUCTURE (2010)
Immunization by influenza virus-like particles protects aged mice against lethal influenza virus challenge
Zhiyuan Wen et al.
ANTIVIRAL RESEARCH (2009)
Analysis of Neutralization Specificities in Polyclonal Sera Derived from Human Immunodeficiency Virus Type 1-Infected Individuals
Yuxing Li et al.
JOURNAL OF VIROLOGY (2009)
Characterization of a trimeric MPER containing HIV-1 gp41 antigen
Andreas Hinz et al.
VIROLOGY (2009)
A brief history of HIV vaccine research: stepping back to the drawing board?
Frank Miedema
AIDS (2008)
HIV-1 broadly neutralizing antibody extracts its epitope from a kinked gp41 ectodomain region on the viral membrane
Zhen-Yu J. Sun et al.
IMMUNITY (2008)
Importance of the membrane-perturbing properties of the membrane-proximal external region of human immunodeficiency virus type 1 gp41 to viral fusion
Sundararn A. Vishwanathan et al.
JOURNAL OF VIROLOGY (2008)
Challenges in the development of an HIV-1 vaccine
Dan H. Barouch
NATURE (2008)
The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus
Gunilla B. Karlsson Hedestam et al.
NATURE REVIEWS MICROBIOLOGY (2008)
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design
Marinieve Montero et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
Perspective - HIV vaccine research: The way forward
Anthony S. Fauci et al.
SCIENCE (2008)
Analysis of the human immunodeficiency virus type 1 gp41 membrane proximal external region arrayed on hepatitis B surface antigen particles
S. Phogat et al.
VIROLOGY (2008)
4E10-resistant variants in a human immunodeficiency virus type 1 subtype C-infected individual with an anti-membrane-proximal external region-neutralizing antibody response
Elin S. Gray et al.
JOURNAL OF VIROLOGY (2008)
Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state
Mikyung Kim et al.
VACCINE (2007)
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection
E. S. Gray et al.
JOURNAL OF VIROLOGY (2007)
Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors
Amandeep K. Dhillon et al.
JOURNAL OF VIROLOGY (2007)
Antigenic and immunogenic study of membrane-proximal external region-grafted gp120 antigens by a DNA prime-protein boost immunization strategy
Mansun Law et al.
JOURNAL OF VIROLOGY (2007)
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand
Punnee Pitisuttithum et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Antigenic properties of a transport-competent influenza HA/HIV Env chimeric protein
Ling Ye et al.
VIROLOGY (2006)
Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (HIV-1)-specific ipitopes: Replication, neutralization, and survey of HIV-1-positive plasma
E Yuste et al.
JOURNAL OF VIROLOGY (2006)
Induction of neutralizing antibody against human immunodeficiency virus type 1 (HIV-1) by immunization with gp41 membrane-proximal external region (MPER) fused with porcine endogenous retrovirus (PERV) p15E fragment
M Luo et al.
VACCINE (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
Conformational constraints imposed on a pan-neutralizing HIV-1 antibody epitope result in increased antigenicity but not neutralizing response
J Ho et al.
VACCINE (2005)
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1
MB Zwick et al.
JOURNAL OF VIROLOGY (2005)
Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: Role of the cytoplasmic domain
L Ye et al.
JOURNAL OF VIROLOGY (2004)
Enhancement of immunogenicity of an HIV Env DNA vaccine by mutation of the Tyr-based endocytosis motif in the cytoplasmic domain
ZG Bu et al.
VIROLOGY (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gpl120 is sterically restricted on primary human immunodeficiency virus type 1
AF Labrijn et al.
JOURNAL OF VIROLOGY (2003)
A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1
G Stiegler et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2001)
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41
MB Zwick et al.
JOURNAL OF VIROLOGY (2001)
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140
PL Earl et al.
JOURNAL OF VIROLOGY (2001)
Antigenicity and immunogenicity of the HIV-1 gp41 epitope ELDKWA inserted into permissive sites of the MalE protein
E Coëffier et al.
VACCINE (2000)
Current evidence and future directions for targeting HIV entry - Therapeutic and prophylactic strategies
MP D'Souza et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Production and characterization of simian-human immunodeficiency virus-like particles
QZ Yao et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2000)
Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization
AN Vzorov et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
